These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12885873)

  • 1. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.
    Cowley SC; Elkins KL
    J Exp Med; 2003 Aug; 198(3):379-89. PubMed ID: 12885873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
    Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
    J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Yee D; Rhinehart-Jones TR; Elkins KL
    J Immunol; 1996 Dec; 157(11):5042-8. PubMed ID: 8943413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential requirements by CD4+ and CD8+ T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth.
    Cowley SC; Sedgwick JD; Elkins KL
    J Immunol; 2007 Dec; 179(11):7709-19. PubMed ID: 18025217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS.
    Elkins KL; Colombini SM; Krieg AM; De Pascalis R
    Microbes Infect; 2009 Jan; 11(1):49-56. PubMed ID: 18992838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.
    Bosio CM; Elkins KL
    Infect Immun; 2001 Jan; 69(1):194-203. PubMed ID: 11119506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.
    Polsinelli T; Meltzer MS; Fortier AH
    J Immunol; 1994 Aug; 153(3):1238-45. PubMed ID: 8027551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication.
    Collazo CM; Sher A; Meierovics AI; Elkins KL
    Microbes Infect; 2006 Mar; 8(3):779-90. PubMed ID: 16513388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism.
    Anthony LS; Morrissey PJ; Nano FE
    J Immunol; 1992 Mar; 148(6):1829-34. PubMed ID: 1541823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An
    Golovliov I; Lindgren H; Eneslätt K; Conlan W; Mosnier A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
    [No Abstract]   [Full Text] [Related]  

  • 11. Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans.
    Sjöstedt A; Eriksson M; Sandström G; Tärnvik A
    Immunology; 1992 Aug; 76(4):584-92. PubMed ID: 1356911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of Francisella tularensis Intracellular Growth by Pulmonary Epithelial Cells.
    Maggio S; Takeda K; Stark F; Meierovics AI; Yabe I; Cowley SC
    PLoS One; 2015; 10(9):e0138565. PubMed ID: 26379269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain.
    Gosselin EJ; Gosselin DR; Lotz SA
    Hum Immunol; 2005 Oct; 66(10):1039-49. PubMed ID: 16386645
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Khan H; Bhargava V; Elkins KL
    Microbiol Spectr; 2024 Aug; 12(8):e0002824. PubMed ID: 38940590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
    Cowley SC; Hamilton E; Frelinger JA; Su J; Forman J; Elkins KL
    J Exp Med; 2005 Jul; 202(2):309-19. PubMed ID: 16027239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70.
    Elkins KL; Cooper A; Colombini SM; Cowley SC; Kieffer TL
    Infect Immun; 2002 Apr; 70(4):1936-48. PubMed ID: 11895957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of IFN-γ by splenic dendritic cells during innate immune responses against Francisella tularensis LVS depends on MyD88, but not TLR2, TLR4, or TLR9.
    De Pascalis R; Rossi AP; Mittereder L; Takeda K; Akue A; Kurtz SL; Elkins KL
    PLoS One; 2020; 15(8):e0237034. PubMed ID: 32745117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain.
    Cowley SC; Goldberg MF; Ho JA; Elkins KL
    J Infect Dis; 2008 Jul; 198(2):284-92. PubMed ID: 18593295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.
    Woolard MD; Hensley LL; Kawula TH; Frelinger JA
    Infect Immun; 2008 Jun; 76(6):2651-9. PubMed ID: 18391003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.
    Melillo AA; Foreman O; Bosio CM; Elkins KL
    Infect Immun; 2014 Apr; 82(4):1477-90. PubMed ID: 24421047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.